Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan 8;22(2):588.
doi: 10.3390/ijms22020588.

CHD2-Related CNS Pathologies

Affiliations
Review

CHD2-Related CNS Pathologies

Marc-Michel Wilson et al. Int J Mol Sci. .

Abstract

Epileptic encephalopathies (EE) are severe epilepsy syndromes characterized by multiple seizure types, developmental delay and even regression. This class of disorders are increasingly being identified as resulting from de novo genetic mutations including many identified mutations in the family of chromodomain helicase DNA binding (CHD) proteins. In particular, several de novo pathogenic mutations have been identified in the gene encoding chromodomain helicase DNA binding protein 2 (CHD2), a member of the sucrose nonfermenting (SNF-2) protein family of epigenetic regulators. These mutations in the CHD2 gene are causative of early onset epileptic encephalopathy, abnormal brain function, and intellectual disability. Our understanding of the mechanisms by which modification or loss of CHD2 cause this condition remains poorly understood. Here, we review what is known and still to be elucidated as regards the structure and function of CHD2 and how its dysregulation leads to a highly variable range of phenotypic presentations.

Keywords: CHD2; developmental epileptic encephalopathy; epigenetics.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Domain composition of human CHD proteins. The 9 known human chromodomain helicase DNA binding (CHD) proteins, divided into their appropriate subfamilies and drawn approximately to scale with all known or predicted domains included. All structural information was derived from Uniprot [32], InterPro [33], PFAM [34] and the National Center for Biotechnology Information (NCBI) [35] web sites. (Image created in BioRender® [36]).

Similar articles

Cited by

References

    1. Workman J.L., Kingston R.E. Alteration of Nucleosome Structure as a Mechanism of Transcriptional Regulation. Annu. Rev. Biochem. 1998;67:545–579. doi: 10.1146/annurev.biochem.67.1.545. - DOI - PubMed
    1. Jiang C., Pugh B.F. Nucleosome Positioning and Gene Regulation: Advances through Genomics. Nat. Rev. Genet. 2009;10:161–172. doi: 10.1038/nrg2522. - DOI - PMC - PubMed
    1. Li B., Carey M., Workman J.L. The Role of Chromatin during Transcription. Cell. 2007;128:707–719. doi: 10.1016/j.cell.2007.01.015. - DOI - PubMed
    1. Struhl K. Histone Acetylation and Transcriptional Regulatory Mechanisms. Genes Dev. 1998;12:599–606. doi: 10.1101/gad.12.5.599. - DOI - PubMed
    1. Clapier C.R., Cairns B.R. The Biology of Chromatin Remodeling Complexes. Annu. Rev. Biochem. 2009;78:273–304. doi: 10.1146/annurev.biochem.77.062706.153223. - DOI - PubMed

MeSH terms

LinkOut - more resources